Article Data

  • Views 184
  • Dowloads 135

Original Research

Open Access

The role of the mode of delivery in the alteration of intrapartum pathological cervical cytologic findings during the postpartum period

  • Ch. Siristatidis1
  • N. Vitoratos1
  • E. Michailidis1
  • C. Syciotis1
  • N. Panagiotopoulos1
  • D. Kassanos1
  • E. Salamalekis1,*,

12nd Department of Obstetrics and Gynaecology, University of Athens, Areteion Hospital, Greece

DOI: 10.12892/ejgo200204358 Vol.23,Issue 4,July 2002 pp.358-360

Published: 10 July 2002

*Corresponding Author(s): E. Salamalekis E-mail:

Abstract

Objective: The aim of the study was to determine whether abnormal antepartum cervical cytologic findings change in the postpartum period and the relation of this alteration to the mode of delivery.

Study design: Between 1991 and 2000, 192 pregnant women with antepartum abnormal cervical cytology were identified; complete demographic, clinical and cytologic reports were available for 90 of them. Papanicolaou smear tests were collected and separated in three groups using the Bethesda classification system (ASCUS, L-SIL and H-SIL).

Results: Of the 90 women, 52 (61.1%) were delivered vaginally and 38 (38.9%) by cesarean section. No difference was found between women delivered vaginally and those delivered by cesarean section, regardin age, parity and smoking history. The overall postpartum regression rate for the 20 women with antepartum H-SIL cells was 45%. Of the 12 women with H-SIL cells who were delivered vaginally, eight (66.6%) showed regression in the postpartum period while this regression was achieved only in one (12.5%) woman, who was delivered by cesarean section (p < 0.002).

Conclusion: Postpartum spontaneous regression of suspicious Papanicolaou smears consistent with H-SIL occurs with increased frequency among women who are delivered vaginally compared to those delivered by cesarean section.

Keywords

Cervical intraepithelial neoplasia; Pap test; Mode of delivery; Pregnancy


Cite and Share

Ch. Siristatidis,N. Vitoratos,E. Michailidis,C. Syciotis,N. Panagiotopoulos,D. Kassanos,E. Salamalekis. The role of the mode of delivery in the alteration of intrapartum pathological cervical cytologic findings during the postpartum period. European Journal of Gynaecological Oncology. 2002. 23(4);358-360.

References

[1] Pfenninger J. L.: "Colposcopy in a family practice residency; the first 200 cases". J. Fam. Pract., 1992, 34. 67.

[2] Penna C., F allani M. G., Maggiorelli M., Zipoli E., Cardelli A., Marchionni M.: "High-grade cervical intraepithelial neoplasia (CIN) in pregnancy: clinicotherapeutic management". Tumori, 1998, 84 (5), 567.

[3] Kohan S.. Beckman E. M.. Bigelow B., Klein S. A., Douglas G W.: "T he role of colposcopy in the management of cervical intraepithelial neoplasia during pregnancy and postpartum". J. Rep rod Med., 1980, 25, 279.

[4] Benedet J. L., Selke P. A., Nickerson K. G.: "Colposcopic evaluation of abnormal Papanicolaou smears in pregnancy". Am. J Obstet. Gynecol., 1987, 157, 932.

[5] Ahdoot D., Van Nostrand K. M., Nguyen N. J., Tewari D.S., Kurasaki T., Di Saia P. J., Rose G. S.: "T he effect of route of delivery on regression of abnormal cervical cytologic findings in the postpartum period".Am. J. Ohstet. Gynecol., 1998, 178 (6丿,1116.

[6] Yost N. P., Santoso J. T., McIntire S.S.. Lliya F. A.: "Postpartum regression rates of antepartum cervical intraepithelial neoplasia II and III lesions". Ohstet. Gynecol., 1999, 93(3), 359.

[7] Michael C. W., Esfahani F. M.: "Pregnancy-related changes: a retrospective review of 278 cervical smears". Diagn. Cytopatol., 1997, 17 (2), 99.

[8] Melnikow J., Nuovo J., Willan A. R., Chan B. K., Howell L. P.: "Natural history of cervical squamous intraepithelial lesions: a meta-analysis". Obstet. Gynecol., 1998, 92, 727.

[9] Kigushi K., Bibbo M., Hasegawa T., Kurihara S., Tsutsui F., Wied GIN.: "Dysplasia during pregnancy: a cytologic follow-up study" J. Reprod. Med., 1981, 26, 66.

[10] Yoonessi M., Wieckowska W., Mariniello D., Antkowiak J.: "Cervical intra-epithelial neoplasia during pregnancy". Int. J. Gynecol Ohstet., 1982, 20, 111.

[11] Kaplan A. L., Kaufman R. H.: "Diagnosis and management of dysplasia and carcinoma in situ of the cervix in pregnancy". Clin. Ohstet. Gynecol., 1967, 10, 871.

[12] Palle C., Bangsboll S., Andreasson B.: "Cervical intraepithelial neoplasia in pregnancy". Acta Ohstet. et Gynecol. Scand., 2000, 79 (4), 306.

[13] Giraud J. R., Poulain P., Renaud-Giono A., Burtin F., Burtin J. F., Proudhon J. F., Leveque J.: "CIN and pregnancy. A propos of 16 cases and review of the literature". Gynecol. Obstet. Bio. Reprod. (Paris), 1997, 26 (5), 496.

[14] Jain A. G., Higgins R. V., Boyle M. J.: "Management of low-grade squamous intraepithelial lesions during pregnancy". Am. J. Obstet Gynecol., 1997, 177, 298.

[15] Hall J.E., Walton L.: "Dysplasia of the cervix: a prospective study of 206 cases". Am. J. Obstet. Gynecol., 1968, 100, 662.

[16J Guerra B., De Simone P., Gabrielli S., Fico P., Montanari G .. Bovicelli L.: "Combined cytology and colposcopy to screen for cervical cancer in pregnancy". J. Reprod. Med., 1998, 43 (8), 647.

[17] Madej J. G., Jr.: "Colposcopy monitoring in pregnancy complicated by CIN and early cervical cancer". Eur. J. Gynaecol. Oncol., 1996, 17 (1), 59.

[18] Baldauf J. J., Dreyfus M., Gao J., Ritter J., Philippe E.: "Management of pregnant women with abnormal cervical smears. A series of 146 patients". J. Gynecol. Obstet. Biol. Reprod. (Paris), 1996, 25 (6), 582.

[19] Coppola A., Sorosky J., Casper R., Anderson B., Buller R. E.: 'The clinical course of cervical carcinoma in situ diagnosed during pregnancy". Gynecol. Oneal., 1997, 67 (2), 162.

[20] Woodrow N., P ermezel M., Butterfield L., Rome R., Tan J., Qmnn M.: "Abnormal cervical cytology in pregnancy: experience of 811 cases". Aust.N. Z. J. Obstet. Gynaecol., 1998, 38 (2), 161.

[21] Fukuda K., Hachisuga T., Nakamura S、Matsuo N., Twasaka T., Sugimori H.: "Local immune respon沁in persisten cervical dysplasia". Obstet. Gynecol., 1993, 82, 941.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top